Immunic, Inc. Common Stock (IMUX) is a publicly traded Healthcare sector company. As of July 14, 2026, IMUX trades at $15.36 with a market cap of $201.19M and a P/E ratio of -23.76. IMUX moved +2.53% today. Year to date, IMUX is +186.95%; over the trailing twelve months it is +76.36%. Its 52-week range spans $5.06 to $15.84. Analyst consensus is strong buy with an average price target of $29.80. Rallies surfaces IMUX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for IMUX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $15.36 |
| Market Cap | $201.19M |
| P/E Ratio | -23.76 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.84 |
| 52-Week Low | $5.06 |
| Volume | 55.63K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-97.17M |
| Gross Margin | 0.00% |
7 analysts cover IMUX: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.80.